腸外包裝市場機會、成長動力、產業趨勢分析與 2025 - 2034 年預測

2024 年全球腸外包裝市場價值為 256 億美元，預估 2025 年至 2034 年期間複合年成長率為 6.1%。這一成長主要受即用型包裝解決方案需求不斷成長的推動。這些解決方案在提高藥物穩定性、降低污染風險和降低生產成本方面發揮關鍵作用。隨著醫療保健領域的發展，受生物製劑和個人化醫療進步的推動，注射藥物的趨勢日益明顯。這一趨勢推動了市場擴張，製藥和生物技術公司優先考慮高品質的無菌包裝，以確保其產品的安全性和有效性。

此外，醫院和家庭醫療保健環境對先進藥物輸送系統的需求不斷成長，為創新包裝解決方案創造了重大機會。包裝材料和形式的技術進步使得藥物管理更加方便、安全和高效，並使腸外包裝成為現代醫療實踐的基石。

市場根據產品類型細分，主要類別包括藥筒、小瓶和安瓿瓶、預充式注射器、輸液瓶和袋、泡殼包裝和其他形式。預充式注射器將主導市場，到 2034 年將創造 100 億美元的收入。向自我管理的轉變使預充式注射器成為患者和醫療保健提供者的首選。它們能夠透過提供預先測量的劑量來最大限度地減少用藥錯誤，這使它們成為各種治療領域的理想選擇。隨著全球慢性病持續增加以及對精確劑量的需求不斷增加，對預充式注射器的需求仍然強勁。

材料選擇在市場動態中起著關鍵作用，其中玻璃、塑膠、紙和紙板是主要選擇。玻璃領域預計將經歷最高的成長，預計 2025 年至 2034 年的複合年成長率為 7%。玻璃因其非反應性而受到青睞，使其成為保存敏感注射藥物（包括生物製劑和疫苗）完整性的理想選擇。其惰性確保藥物化合物保持穩定、無菌、不受化學分解或污染，為高價值治療藥物在整個保存期限內提供無與倫比的保護。

北美在全球腸外包裝市場佔有相當大的佔有率，到 2024 年將達到 35%。美國引領區域市場，不斷擴張的製藥和生物技術產業推動了對尖端包裝解決方案的需求。該國強大的醫療保健基礎設施，加上對藥物開發不斷增加的投資，支持了市場持續成長。隨著對病患安全和法規遵循的關注度不斷提高，確保藥物穩定性、易用性和高效輸送的複雜包裝技術正在成為標準。該地區對醫療保健和製藥製造業創新的承諾將推動腸外包裝市場的長期成長。

目錄

第 1 章：方法論與範圍

• 市場範圍和定義
• 基礎估算與計算
• 預測計算
• 資料來源
  • 基本的
  • 次要
    • 付費來源
    • 公共資源

第 2 章：執行摘要

第 3 章：產業洞察

• 產業生態系統分析
  • 影響價值鏈的因素
  • 利潤率分析
  • 中斷
  • 未來展望
  • 製造商
  • 經銷商
• 重要新聞及舉措
• 監管格局
• 衝擊力
  • 成長動力
    • 生物製劑和注射劑的需求不斷成長
    • 即用型包裝解決方案的普及
    • 包裝材料的技術進步
    • 監理要求提高安全標準
    • 擴大新興市場的醫療基礎設施
  • 產業陷阱與挑戰
    • 先進封裝生產成本高
    • 客製化包裝解決方案的複雜性
• 成長潛力分析
• 波特的分析
• PESTEL 分析

第4章：競爭格局

• 介紹
• 公司市佔率分析
• 競爭定位矩陣
• 戰略展望矩陣

第 5 章：市場估計與預測：按材料類型，2021-2034 年

• 主要趨勢
• 玻璃
• 塑膠
• 紙和紙板
• 其他

第 6 章：市場估計與預測：按產品類型，2021-2034 年

• 主要趨勢
• 小瓶和安瓿瓶
• 墨水匣
• 預充式注射器
• 點滴瓶和輸液袋
• 泡殼包裝
• 其他

第 7 章：市場估計與預測：依封裝類型，2021-2034 年

• 主要趨勢
• 初級包裝
• 二次包裝
• 三級包裝

第 8 章：市場估計與預測：按地區，2021 年至 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙
  • 俄羅斯
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲
• 拉丁美洲
  • 巴西
  • 墨西哥
• 中東及非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第9章：公司簡介

• Adelphi Group
• Amcor
• AptarGroup
• Baxter International
• Berry Global
• Catalent
• Datwyler
• Gerresheimer
• Nipro
• Oliver Healthcare Packaging
• Schott
• SGD Pharma
• Stevanato Group
• Tekni-Plex
• West Pharmaceutical Services
• WestRock

The Global Parenteral Packaging Market is valued at USD 25.6 billion in 2024 and is projected to expand at a CAGR of 6.1% from 2025 to 2034. This growth is primarily driven by the increasing demand for ready-to-use packaging solutions. These solutions play a critical role in enhancing drug stability, reducing the risk of contamination, and lowering production costs. As the healthcare landscape evolves, there is a growing shift toward injectable drugs propelled by advancements in biologics and personalized medicine. This trend is fueling market expansion, with pharmaceutical and biotechnology companies prioritizing high-quality, sterile packaging to guarantee the safety and efficacy of their products.

Furthermore, the rising need for advanced drug delivery systems in both hospital and home healthcare settings is creating significant opportunities for innovative packaging solutions. Technological advancements in packaging materials and formats are making drug administration more convenient, safer, and efficient, establishing parenteral packaging as a cornerstone in modern healthcare practices.

The market is segmented based on product type, with key categories including cartridges, vials and ampoules, prefilled syringes, infusion solution bottles and bags, blister packs, and other formats. Prefilled syringes are poised to dominate the market, generating USD 10 billion in revenue by 2034. The shift towards self-administration has positioned prefilled syringes as a preferred option for patients and healthcare providers alike. Their ability to minimize medication errors by offering pre-measured doses makes them an ideal choice for a variety of therapeutic areas. As chronic diseases continue to rise globally and the demand for precise dosages intensifies, the need for prefilled syringes remains strong.

Material selection plays a pivotal role in the market's dynamics, with glass, plastic, paper, and paperboard being the primary options. The glass segment is expected to experience the highest growth, with a projected CAGR of 7% from 2025 to 2034. Glass is favored for its non-reactive properties, making it the ideal choice for preserving the integrity of sensitive injectable drugs, including biologics and vaccines. Its inert nature ensures that pharmaceutical compounds remain stable, sterile, and free from chemical degradation or contamination, offering unparalleled protection for high-value therapeutics throughout their shelf life.

North America holds a significant share of the global parenteral packaging market, accounting for 35% in 2024. The United States leads the regional market, with the expanding pharmaceutical and biotechnology sectors fueling the demand for cutting-edge packaging solutions. The country's strong healthcare infrastructure, combined with increasing investments in drug development, supports continued market growth. As the focus on patient safety and regulatory compliance intensifies, sophisticated packaging technologies that ensure drug stability, ease of use, and efficient delivery are becoming the standard. The commitment to innovation in healthcare and pharmaceutical manufacturing in the region is set to drive long-term growth in the parenteral packaging market.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Base estimates & calculations
• 1.3 Forecast calculations
• 1.4 Data sources
  • 1.4.1 Primary
  • 1.4.2 Secondary
    • 1.4.2.1 Paid sources
    • 1.4.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Industry synopsis, 2022-2034

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Factor affecting the value chain
  • 3.1.2 Profit margin analysis
  • 3.1.3 Disruptions
  • 3.1.4 Future outlook
  • 3.1.5 Manufacturers
  • 3.1.6 Distributors
• 3.2 Key news & initiatives
• 3.3 Regulatory landscape
• 3.4 Impact forces
  • 3.4.1 Growth drivers
    • 3.4.1.1 Rising demand for biologics and injectables
    • 3.4.1.2 Popularity of ready-to-use packaging solutions
    • 3.4.1.3 Technological advancements in packaging materials
    • 3.4.1.4 Regulatory requirements boosting safety standards
    • 3.4.1.5 Expanding healthcare infrastructure in emerging markets
  • 3.4.2 Industry pitfalls & challenges
    • 3.4.2.1 High production costs of advanced packaging
    • 3.4.2.2 Complexity in customizing packaging solutions
• 3.5 Growth potential analysis
• 3.6 Porter’s analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive positioning matrix
• 4.4 Strategic outlook matrix

Chapter 5 Market Estimates & Forecast, By Material Type, 2021-2034 (USD Billion & Kilo Tons)

• 5.1 Key trends
• 5.2 Glass
• 5.3 Plastic
• 5.4 Paper and paperboard
• 5.5 Others

Chapter 6 Market Estimates & Forecast, By Product Type, 2021-2034 (USD Billion & Kilo Tons)

• 6.1 Key trends
• 6.2 Vials & ampoules
• 6.3 Cartridges
• 6.4 Prefilled syringes
• 6.5 Infusion solutions bottles & bags
• 6.6 Blister packs
• 6.7 Others

Chapter 7 Market Estimates & Forecast, By Packaging Type, 2021-2034 (USD Billion & Kilo Tons)

• 7.1 Key trends
• 7.2 Primary packaging
• 7.3 Secondary packaging
• 7.4 Tertiary packaging

Chapter 8 Market Estimates & Forecast, By Region, 2021-2034 (USD Billion & Kilo Tons)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 UK
  • 8.3.2 Germany
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Russia
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 India
  • 8.4.3 Japan
  • 8.4.4 South Korea
  • 8.4.5 Australia
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
• 8.6 MEA
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Adelphi Group
• 9.2 Amcor
• 9.3 AptarGroup
• 9.4 Baxter International
• 9.5 Berry Global
• 9.6 Catalent
• 9.7 Datwyler
• 9.8 Gerresheimer
• 9.9 Nipro
• 9.10 Oliver Healthcare Packaging
• 9.11 Schott
• 9.12 SGD Pharma
• 9.13 Stevanato Group
• 9.14 Tekni-Plex
• 9.15 West Pharmaceutical Services
• 9.16 WestRock